Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2018 Filed May 4, 2018 00:42 UTC |
ROBIN HOWARD WDirector · President & CEO
|
Exercise / conversionCommon Stock | 43,333 | $10.69 | $463,229.77 |
DisclosureSEC source: 0001209191-18-027941 · doc4.xml · nonDerivative · entry 3 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for options expiring in the next 12 months. Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:43 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $10.69 | $0.00 |
DisclosureSEC source: 0001209191-18-027942 · doc4.xml · derivative · entry 7 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 30,000 shares Expires 2019-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for options expiring in the next 12 months. Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:43 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
SaleCommon Stock | 30,000 | $83.65 | $2,509,500.00 |
DisclosureSEC source: 0001209191-18-027942 · doc4.xml · nonDerivative · entry 2 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,739 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for options expiring in the next 12 months. F3 · price: This transaction was executed in multiple trades at prices ranging from $82.60 to $84.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:43 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 30,000 | $10.69 | $320,700.00 |
DisclosureSEC source: 0001209191-18-027942 · doc4.xml · nonDerivative · entry 1 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for options expiring in the next 12 months. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:42 UTC |
ROBIN HOWARD WDirector · President & CEO
|
Exercise / conversionStock Option · Derivative | 43,334 | $0.00 Strike: $10.69 | $0.00 |
DisclosureSEC source: 0001209191-18-027941 · doc4.xml · derivative · entry 8 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,666 Underlying: Common Stock · 43,334 shares Expires 2019-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for options expiring in the next 12 months. Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:42 UTC |
ROBIN HOWARD WDirector · President & CEO
|
SaleCommon Stock | 43,334 | $83.65 | $3,624,889.10 |
DisclosureSEC source: 0001209191-18-027941 · doc4.xml · nonDerivative · entry 2 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,147 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for options expiring in the next 12 months. F2 · price: This transaction was executed in multiple trades at prices ranging from $82.60 to $84.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:42 UTC |
ROBIN HOWARD WDirector · President & CEO
|
Exercise / conversionCommon Stock | 43,334 | $10.69 | $463,240.46 |
DisclosureSEC source: 0001209191-18-027941 · doc4.xml · nonDerivative · entry 1 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for options expiring in the next 12 months. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 22:05 UTC |
WHITFIELD ROY ADirector
|
Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $14.26 | $0.00 |
DisclosureSEC source: 0001209191-18-025446 · doc4.xml · derivative · entry 3 WHITFIELD ROY A · CIK 0000936728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2018-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 22:05 UTC |
WHITFIELD ROY ADirector
|
Exercise / conversionCommon Stock | 30,000 | $14.26 | $427,800.00 |
DisclosureSEC source: 0001209191-18-025446 · doc4.xml · nonDerivative · entry 1 WHITFIELD ROY A · CIK 0000936728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 22:03 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
Exercise / conversionStock Option · Derivative | 13,881 | $0.00 Strike: $10.69 | $0.00 |
DisclosureSEC source: 0001209191-18-025445 · doc4.xml · derivative · entry 3 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,119 Underlying: Common Stock · 13,881 shares Expires 2019-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 22:03 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
SaleCommon Stock | 13,881 | $101.46 | $1,408,366.26 |
DisclosureSEC source: 0001209191-18-025445 · doc4.xml · nonDerivative · entry 2 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,857 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $100.21 to $101.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 3,703 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 22:03 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 13,881 | $10.69 | $148,387.89 |
DisclosureSEC source: 0001209191-18-025445 · doc4.xml · nonDerivative · entry 1 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 3,703 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| April 10, 2018 Filed Apr 12, 2018 22:05 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
Exercise / conversionStock Option · Derivative | 502 | $0.00 Strike: $7.21 | $0.00 |
DisclosureSEC source: 0001209191-18-024772 · doc4.xml · derivative · entry 3 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 502 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 10, 2018 Filed Apr 12, 2018 22:05 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
SaleCommon Stock | 502 | $105.67 | $53,046.34 |
DisclosureSEC source: 0001209191-18-024772 · doc4.xml · nonDerivative · entry 2 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,261 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $105.03 to $105.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 6,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| April 10, 2018 Filed Apr 12, 2018 22:05 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
Exercise / conversionCommon Stock | 502 | $7.21 | $3,619.42 |
DisclosureSEC source: 0001209191-18-024772 · doc4.xml · nonDerivative · entry 1 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This number includes 6,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 00:22 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
Exercise / conversionStock Option · Derivative | 9,498 | $0.00 Strike: $7.21 | $0.00 |
DisclosureSEC source: 0001209191-18-024453 · doc4.xml · derivative · entry 6 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,002 Underlying: Common Stock · 9,498 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 00:22 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
SaleCommon Stock | 9,498 | $105.05 | $997,764.90 |
DisclosureSEC source: 0001209191-18-024453 · doc4.xml · nonDerivative · entry 4 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,261 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: This transaction was executed in multiple trades at prices ranging from $105.00 - $105.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 6,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 00:22 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
Exercise / conversionCommon Stock | 9,498 | $7.21 | $68,480.58 |
DisclosureSEC source: 0001209191-18-024453 · doc4.xml · nonDerivative · entry 3 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This number includes 6,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionStock Option · Derivative | 49,500 | $0.00 Strike: $7.21 | $0.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · derivative · entry 10 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,500 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
SaleCommon Stock | 49,500 | $96.13 | $4,758,435.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · nonDerivative · entry 6 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,394 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $94.99 to $96.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 49,500 | $7.21 | $356,895.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · nonDerivative · entry 5 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionStock Option · Derivative | 500 | $0.00 Strike: $7.21 | $0.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · derivative · entry 9 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,500 Underlying: Common Stock · 500 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionStock Option · Derivative | 50,000 | $0.00 Strike: $7.21 | $0.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · derivative · entry 8 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionStock Option · Derivative | 60,000 | $0.00 Strike: $10.69 | $0.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · derivative · entry 7 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2019-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
SaleCommon Stock | 110,500 | $91.69 | $10,131,745.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · nonDerivative · entry 4 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,394 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $89.98 to $94.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 500 | $7.21 | $3,605.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · nonDerivative · entry 3 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 50,000 | $7.21 | $360,500.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · nonDerivative · entry 2 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:21 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 60,000 | $10.69 | $641,400.00 |
DisclosureSEC source: 0001209191-18-024451 · doc4.xml · nonDerivative · entry 1 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:22 UTC |
GREER R SCOTTDirector
|
Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $14.26 | $0.00 |
DisclosureSEC source: 0001209191-18-024452 · doc4.xml · derivative · entry 3 GREER R SCOTT · CIK 0001211703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2018-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:22 UTC |
GREER R SCOTTDirector
|
SaleCommon Stock | 30,000 | $92.22 | $2,766,600.00 |
DisclosureSEC source: 0001209191-18-024452 · doc4.xml · nonDerivative · entry 2 GREER R SCOTT · CIK 0001211703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,333 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $90.05 to $94.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:22 UTC |
GREER R SCOTTDirector
|
Exercise / conversionCommon Stock | 30,000 | $14.26 | $427,800.00 |
DisclosureSEC source: 0001209191-18-024452 · doc4.xml · nonDerivative · entry 1 GREER R SCOTT · CIK 0001211703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:20 UTC |
CHESS ROBERTDirector
|
Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0001209191-18-024450 · doc4.xml · derivative · entry 6 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2019-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:20 UTC |
CHESS ROBERTDirector
|
Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $14.26 | $0.00 |
DisclosureSEC source: 0001209191-18-024450 · doc4.xml · derivative · entry 5 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2018-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:20 UTC |
CHESS ROBERTDirector
|
SaleCommon Stock | 15,000 | $92.14 | $1,382,100.00 |
DisclosureSEC source: 0001209191-18-024450 · doc4.xml · nonDerivative · entry 4 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,223 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $90.19 to $94.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:20 UTC |
CHESS ROBERTDirector
|
Exercise / conversionCommon Stock | 15,000 | $5.14 | $77,100.00 |
DisclosureSEC source: 0001209191-18-024450 · doc4.xml · nonDerivative · entry 3 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:20 UTC |
CHESS ROBERTDirector
|
SaleCommon Stock | 10,000 | $92.15 | $921,500.00 |
DisclosureSEC source: 0001209191-18-024450 · doc4.xml · nonDerivative · entry 2 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,223 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $90.15 to $94.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 00:20 UTC |
CHESS ROBERTDirector
|
Exercise / conversionCommon Stock | 10,000 | $14.26 | $142,600.00 |
DisclosureSEC source: 0001209191-18-024450 · doc4.xml · nonDerivative · entry 1 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2018 Filed Apr 10, 2018 00:23 UTC |
Lingnau LutzDirector
|
Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001209191-18-024454 · doc4.xml · derivative · entry 3 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 30,000 shares Expires 2020-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2018 Filed Apr 10, 2018 00:23 UTC |
Lingnau LutzDirector
|
SaleCommon Stock | 30,000 | $101.74 | $3,052,200.00 |
DisclosureSEC source: 0001209191-18-024454 · doc4.xml · nonDerivative · entry 2 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,450 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $100.48 to $103.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 05, 2018 Filed Apr 10, 2018 00:23 UTC |
Lingnau LutzDirector
|
Exercise / conversionCommon Stock | 30,000 | $9.24 | $277,200.00 |
DisclosureSEC source: 0001209191-18-024454 · doc4.xml · nonDerivative · entry 1 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2018 Filed Apr 10, 2018 00:22 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
Exercise / conversionStock Option · Derivative | 20,000 | $0.00 Strike: $7.21 | $0.00 |
DisclosureSEC source: 0001209191-18-024453 · doc4.xml · derivative · entry 5 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 20,000 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2018 Filed Apr 10, 2018 00:22 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
SaleCommon Stock | 20,000 | $101.75 | $2,035,000.00 |
DisclosureSEC source: 0001209191-18-024453 · doc4.xml · nonDerivative · entry 2 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,261 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $100.26 - $103.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 6,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| April 05, 2018 Filed Apr 10, 2018 00:22 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
Exercise / conversionCommon Stock | 20,000 | $7.21 | $144,200.00 |
DisclosureSEC source: 0001209191-18-024453 · doc4.xml · nonDerivative · entry 1 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This number includes 6,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · derivative · entry 8 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2020-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionStock Option · Derivative | 27,400 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · derivative · entry 7 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,400 shares Expires 2019-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC |
KUEBLER CHRISTOPHER ADirector
|
SaleCommon Stock | 37,400 | $97.41 | $3,643,134.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · nonDerivative · entry 5 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,500 F2 · price: This transaction was executed in multiple trades at prices ranging from $96.02 to $98.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionCommon Stock | 10,000 | $9.24 | $92,400.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · nonDerivative · entry 4 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionCommon Stock | 27,400 | $5.14 | $140,836.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · nonDerivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:09 UTC |
Nicholson JohnSVP & Chief Operating Officer
|
SaleCommon Stock | 100,144 | $100.45 | $10,059,464.80 |
DisclosureSEC source: 0001209191-18-018221 · doc4.xml · nonDerivative · entry 2 Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,513 F2 · price: This transaction was executed in multiple trades at prices ranging from $99.00 to $101.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:10 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionStock Option · Derivative | 2,600 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · derivative · entry 6 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,400 Underlying: Common Stock · 2,600 shares Expires 2019-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.